PARP inhibitor combination clinical trials for advanced prostate cancer - Conversation 2

touchMDT for touchONCOLOGY Listen to a urologist and a medical oncologist discuss key clinical trials investigating PARP inhibitor combinations for the treatment of advanced prostate cancer. The multidisciplinary team  Urologist: Professor Axel Merseburger, Germany Medical Oncologist: Dr Wassim Abida, USA This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education grant from Pfizer. This activity is jointly provided by USF Health and touchIME. For further information visit our website: https://touchoncologyime.org/mdt-parp-inhibitor-combinations-in-advanced-prostate-cancer/